Skip to main content
. 2020 Jan 14;9(1):221. doi: 10.3390/jcm9010221

Table 1.

Main characteristics of the included patients.

Variable Total Normal Weight Overweight Obesity p
Age, mean (SD) 55.6 (19.5) 44.6 (20.7) 58.5 (19.2) 61.5 (14.9) 0.000
Gender, n (%)
Male
Female

281 (34.8)
526 (65.2)

87 (37.8)
143 (62.2)

122 (42.4)
166 (57.6)

72 (24.9)
217 (75.1)
0.000
FEV1%
≥80%
≥60–80%
<60%

307 (38.1)
221 (27.4)
278 (34.5)

98 (42.4)
62 (26.8)
71 (30.7)

105 (36.7)
78 (27.3)
103 (36.0)

104 (36.0)
81 (28.0)
104 (36.0)
0.556
Charlson index
0
1
≥2

337 (41.7)
266 (32.9)
206 (25.5)

126 (54.5)
78 (33.8)
27 (11.7)

108 (37.5)
98 (34.0)
82 (28.5)

103 (35.5)
90 (31.0)
97 (33.5)
0.000
Smokers
Never smoker, n (%)
Current smoker, n (%)
Former smoker, n (%)

380 (59.7)
166 (26.1)
90 (14.2)

89 (46.4)
80 (41.7)
23 (12.0)

139 (62.3)
46 (20.6)
38 (17.0)

152 (68.8)
40 (18.1)
29 (13.1)
0.000
Asthma severity
Intermittent, n (%)
Mild, n (%)
Moderate, n (%)
Severe, n (%)

177 (26.2)
168 (24.9)
162 (24.0)
168 (24.9)

71 (34.6)
53 (25.9)
48 (23.4)
33 (16.1)

64 (27.1)
52 (22.0)
60 (25.4)
60 (25.4)

42 (17.9)
63 (26.9)
54 (23.1)
75 (32.1)
0.000
Hospital admissions previous year
0, N (%)
1, N (%)
≥2, N (%)

671 (82.9)
103 (12.7)
35 (4.3)

204 (88.3)
20 (8.7)
7 (3.0)

231 (80.2)
45 (15.6)
12 (4.2)

236 (81.4)
38 (13.1)
16 (5.5)
0.093
Emergency visits previous year
0, N (%)
1–3, N (%)
≥4, N (%)

589 (72.9)
198 (24.5)
21 (2.6)

188 (81.4)
38 (16.5)
5 (2.2)

198 (68.8)
84 (29.2)
6 (2.1)

203 (70.2)
76 (26.3)
10 (3.5)
0.009
ICS-LABA at hospital discharge
No
Yes

244 (30.2)
565 (69.8)

75 (32.5)
156 (67.5)

89 (30.9)
199 (69.1)

80 (27.6)
210 (72.4)
0.456
ICS at hospital discharge
No
Yes

652 (80.6)
157 (19.4)

184 (79.7)
47 (20.3)

225 (78.1)
63 (21.9)

243 (83.8)
47 (16.2)
0.207
OCS at hospital discharge
No
Yes

245 (30.3)
564 (69.7)

71 (30.7)
160 (69.3)

99 (34.4)
189 (65.6)

75 (25.9)
215 (74.1)
0.082

SD: standard deviation; n: number of cases; FEV1%: Forced expiratory volume in the first second, percentage of reference value; ICS-LABA: combination inhaled corticosteroids-long acting beta agonists; ICS: inhaled corticosteroids; OCS: oral corticosteroids.